IMIman Elmahdi Mohamed

Iman Elmahdi Mohamed

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Iman Elmahdi Mohamed has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pharmacovigilance Research: A Bibliometric Performance and Science Mapping Analysis Using the Scopus Database

    by Kannan O. Ahmed, Alka Ahuja, Taha Hussein Musa, Iman Elmahdi Mohamed, Riad Mohammed Abdelrahman, Lukman O. Afolabi, Lovel Fornah

    Background: Pharmacovigilance (PV) is essential for drug safety, but its global development, thematic evolution trends, and collaborative networks are not yet fully mapped. Methods: A bibliometric analysis of Scopus-indexed articles and reviews published between 1960 and 2024 was carried out. Metadata was analyzed using VOSviewer 1.6.20 and the Bibliometrix R package to assess publication trends, influential authors, institutions, countries, co-authorship networks, keyword co-occurrence patterns, and thematic evolution. Multiple Correspondence Analysis and Walktrap clustering were used to map the conceptual structure. Results: A total of 8624 documents were included in the study. Global PV output has increased markedly in the last two decades, with China, the United States, India, and France leading in productivity. Co-authorship networks revealed moderate international collaboration, with emerging economies making a notable contribution. Keyword co-occurrence clusters highlighted major themes, such as adverse drug reactions, PV systems, oncology-related drug safety, and COVID-19 vaccine surveillance. Thematic mapping indicated a shift from foundational ADR reporting to advanced analytical and technology-supported PV methods. Conclusion: PV research is expanding worldwide, with increasing contributions from both high- and middle-income regions. The field demonstrates growing thematic diversification, particularly in oncology and infectious disease PV. Strengthening international collaborations, expanding PV capacity in underrepresented regions, and integrating advanced data analytics are key priorities for future research and policy development.


  • Open Access

    Individuals’ positive gains from the COVID-19 pandemic: a qualitative study across 30 countries

    by Jiaying Li, Patricia M Davidson, Daniel Yee Tak Fong, Yaqin Li, Kris Yuet Wan Lok, Janet Yuen Ha Wong, Mandy Man Ho, Edmond Pui Hang Choi, Vinciya Pandian, Wenjie Duan, et al.

    The COVID-19 pandemic, an unprecedented global crisis, has indelibly reshaped all facets of life globally – health, economy, environment, and societal fabric [1–3]. Major societal events are often transformative. The predominant focus on the pandemic’s negative impacts, necessitates a more balanced perspective to prevent a skewed understanding of its overall impacts. Additionally, unveiling the hidden […]


  • Open Access

    Country-specific key lifestyle factors and health outcomes for resource allocation in the general population: a network analysis across 29 countries

    by Jiaying Li, Daniel Yee Tak Fong, Kris Yuet Wan Lok, Janet Yuen Ha Wong, Mandy Man Ho, Edmond Pui Hang Choi, Vinciya Pandian, Patricia M Davidson, Wenjie Duan, Marie Tarrant, et al.

    Lifestyle factors – including dietary risks, alcohol and tobacco consumption, sedentary behaviours, and physical inactivity – significantly influence health outcomes both immediately and over the long term. Short-term impacts manifest in changes to physical and psychological quality of life [1], sleep [2], and social well-being [3]. Conversely, persistent unhealthy lifestyle behaviours substantially elevate the risk […]


  • The side effects of COVID-19 vaccines: A cross-sectional study in the eastern region of Libya

    by Arwa Benkhaial, Asmaa A. Rabee, Raga A. Elzahaf, Iman Elmahdi, Fatma Benkhaial, Tunis Meidan

    Purpose: Patient-reported data is an important source of safety information. The aim of this study was to describe the side effects of COVID-19 vaccines used in Libya, compare them, and find the association of these with different factors. Materials and Methods: A cross-sectional study was conducted in the eastern part of Libya. Adults who got one or two doses of any COVID-19 vaccine were included. The questionnaire was distributed online via social media, and also distributed as paper form to increase the responses. Results: In total, 1779 adults, (53.7%) females completed the questionnaire. The mean age of participants was 39.87±14.99. Generally, females experienced side effects slightly higher compared to males (75.7% and 68.8% respectively). Overall, the prevalence of side effects was slightly higher in participants aged ≤40 years compared to those aged >40 years (76.5% and 66.6% respectively). However, this difference was found to be statistically significant (p=0.001). The side effects were more common among those previously infected with COVID-19 than those not (78.5% and 21.5%, respectively; p=0.001). The side effects were more common among those, who received the Sputnik V and the Sinopharm vaccine compared to other types. The most common side effect was fever (41.1%), (47.3%) for the Sputnik V vaccine. Conclusion: The side effects of COVID-19 vaccines used in Libya are generally mild and selflimiting. The most common side effect was fever, which was more prominent among females and the younger age group of participants. Also, the side effects were more common among those, who received the Sputnik V vaccine. (Open J Bio Med Res 2022;1:19-27.)